(Q33793887)

29 July 2017

1 reference

title

Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold (English)

1 reference

29 July 2017

1

R Foy

0 references

author name string

J So

series ordinal

2

1 reference

29 July 2017

E Rous

series ordinal

3

1 reference

29 July 2017

J H Scarffe

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 February 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

318

1 reference

29 July 2017

issue

7181

1 reference

29 July 2017

page(s)

456-459

1 reference

Commissioning specialist services in the NHS

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1114914

Docetaxel vs doxorubicin in metastatic breast cancer resistant to alkylating chemotherapy

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1114914

More money is needed to care for patients with cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1114914

Research and development programme begins to bite. Interview by Hilary Bower

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1114914

A purchaser perspective of managing new drugs: interferon beta as a case study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1114914

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1114914

A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1114914

Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients

30 October 2018

1 reference

12 December 2020

Fludarabine in chronic leukaemia

1 reference

12 December 2020

Gemcitabine: clinical and economic impact in inoperable non-small cell lung cancer

1 reference

12 December 2020

Cancer treatments rationed by authority

1 reference

12 December 2020

Cost of Treating Advanced Colorectal Cancer: A Retrospective Comparison of Treatment Regimens

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.318.7181.456

1 reference

29 July 2017

1 reference

29 July 2017

1 reference